Anebulo Pharmaceuticals (ANEB) Income towards Parent Company (2020 - 2025)
Anebulo Pharmaceuticals' Income towards Parent Company was -$2 million in fiscal Q2 2026 (quarter ended Dec 31, 2025), compared with -$2.46 million a year earlier.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Income towards Parent Company (2020 - 2025) Analysis & Trends
On a trailing twelve-month basis, Anebulo Pharmaceuticals' Income towards Parent Company was -$7.99 million through Dec 31, 2025; for FY2025 (ended Jun 30, 2025), it was -$8.5 million.
- In earlier fiscal years, Income towards Parent Company was -$8.2 million in FY2024, -$11.73 million in FY2023, -$6.83 million in FY2022 and -$30.25 million in FY2021.
- Quarterly Income towards Parent Company has moved between -$29.11 million (fiscal Q4 2021) and -$555,832 (fiscal Q3 2021) over five years.
- Per Business Quant data, ANEB's Income towards Parent Company in the three fiscal quarters before Q2 2026 was -$2.16 million (Q1 2026), -$2.16 million (Q4 2025) and -$1.68 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -2.00 Mn |
| Sep 30, 2025 | -2.16 Mn |
| Jun 30, 2025 | -2.16 Mn |
| Mar 31, 2025 | -1.68 Mn |
| Dec 31, 2024 | -2.46 Mn |
| Sep 30, 2024 | -2.20 Mn |
| Jun 30, 2024 | -1.35 Mn |
| Mar 31, 2024 | -1.65 Mn |
| Dec 31, 2023 | -2.72 Mn |
| Sep 30, 2023 | -2.48 Mn |
| Jun 30, 2023 | -2.50 Mn |
| Mar 31, 2023 | -2.80 Mn |
| Dec 31, 2022 | -3.83 Mn |
| Sep 30, 2022 | -2.61 Mn |
| Jun 30, 2022 | -2.32 Mn |
| Mar 31, 2022 | -1.88 Mn |
| Dec 31, 2021 | -1.07 Mn |
| Sep 30, 2021 | -1.55 Mn |
| Jun 30, 2021 | -29.11 Mn |
| Mar 31, 2021 | -555,832.00 |
API Access
Anebulo Pharmaceuticals Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();